Crystallization and transformation of pharmaceutical solid forms

被引:10
作者
Lu, Jie [1 ]
机构
[1] Jiangnan Univ, Sch Chem & Mat Engn, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Peoples R China
基金
中国国家自然科学基金;
关键词
Pharmaceutical technology; forms; crystallization; transformation; CO-CRYSTALS; SOLUBILITY ADVANTAGE; DISSOLUTION RATE; AMORPHOUS STATE; SALT SELECTION; DRUG; POLYMORPHISM; COCRYSTALS; PSEUDOPOLYMORPHISM; NANOPARTICLES;
D O I
10.5897/AJPP12.044
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the past decades, a great progress has been made in the discovery, identification and control of various solid forms of active pharmaceutical ingredients (APIs), including polymorphs, solvates, hydrates, co-crystals, salts and amorphous solids. It is expected that new solid forms with novel properties of pharmaceutical molecules will explosively expand with further understanding of the formation mechanisms of different solid forms. This mini-review briefly introduces the concept, crystallization, characterization, transformation and controlling of various pharmaceutical solid forms by use of exampling some cases.
引用
收藏
页码:581 / 591
页数:11
相关论文
共 80 条
[1]   Building co-crystals with molecular sense and supramolecular sensibility [J].
Aakeröy, CB ;
Salmon, DJ .
CRYSTENGCOMM, 2005, 7 :439-448
[2]   Cocrystal or salt:: Does it really matter? [J].
Aakeroy, Christer B. ;
Fasulo, Meg E. ;
Desper, John .
MOLECULAR PHARMACEUTICS, 2007, 4 (03) :317-322
[3]   High-throughput surveys of crystal form diversity of highly polymorphic pharmaceutical compounds [J].
Almarsson, Ö ;
Hickey, MB ;
Peterson, ML ;
Morissette, SL ;
Soukasene, S ;
McNulty, C ;
Tawa, M ;
MacPhee, JM ;
Remenar, JF .
CRYSTAL GROWTH & DESIGN, 2003, 3 (06) :927-933
[4]   Dissolution and Precipitation Behavior of Amorphous Solid Dispersions [J].
Alonzo, David E. ;
Gao, Yi ;
Zhou, Deliang ;
Mo, Huaping ;
Zhang, Geoff G. Z. ;
Taylor, Lynne S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) :3316-3331
[5]  
[Anonymous], HDB PHARM SALTS PROP
[6]   Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals [J].
Babu, N. Jagadeesh ;
Nangia, Ashwini .
CRYSTAL GROWTH & DESIGN, 2011, 11 (07) :2662-2679
[7]   Ritonavir: An extraordinary example of conformational polymorphism [J].
Bauer, J ;
Spanton, S ;
Henry, R ;
Quick, J ;
Dziki, W ;
Porter, W ;
Morris, J .
PHARMACEUTICAL RESEARCH, 2001, 18 (06) :859-866
[8]  
Bechtloff B, 2001, CRYST RES TECHNOL, V36, P1315, DOI 10.1002/1521-4079(200112)36:12<1315::AID-CRAT1315>3.0.CO
[9]  
2-R
[10]   Characterization of a New Solvate of Risedronate [J].
Bruening, Juergen ;
Petereit, Anna Christine ;
Alig, Edith ;
Bolte, Michael ;
Dressman, Jennifer B. ;
Schmidt, Martin U. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (03) :863-873